Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BXOS110Phase 31 trial
Biocells (Beijing) Biotech Co.,Ltd · AIS
- C2402Not ApplicablePhase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- C2403Phase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- C2407Phase 31 trial
JW Pharmaceutical · Dyslipidemia
- C52R1LPhase 31 trial
AJU Pharm Co., Ltd. · Essential Hypertension
- C52R1MPhase 31 trial
AJU Pharm Co., Ltd. · Essential Hypertension
- CAM-101Elate Ocular, FD hPLPhase 31 trial
Cambium Bio Limited · Dry Eye Disease, Dry Eye, Dry Eyes Chronic
- camrelizumab; famitinib malatePhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Cervical Cancer
- cannabidiol as a clear that can be applied to the skinZYN002, transdermal deliveryPhase 31 trial
Harmony Biosciences Management, Inc. · Fragile X Syndrome, Fragile X Syndrome (FXS)
- CBT-001Phase 31 trial
Cloudbreak Therapeutics, LLC · Pterygium
- celiprololACER-002Phase 31 trial
Acer Therapeutics Inc. · Vascular Ehlers-Danlos Syndrome
- cendakimabCC-93538, BMS-986355Phase 31 trial
Bristol Myers Squibb · Eosinophilic Esophagitis
- CHF10196florensocatibPhase 31 trial
Chiesi Farmaceutici S.p.A. · Bronchiectasis
- CLS2901Chuman [allogeneic] chondrocyte sheetsPhase 31 trial
CellSeed Inc. · Osteoarthritis of the Knee
- CMAB015Phase 31 trial
Taizhou Mabtech Pharmaceutical Co.,Ltd · Psoriasis
- COYA 302Phase 31 trial
Coya Therapeutics · Amyotrophic Lateral Sclerosis (ALS)
- CS-001Phase 31 trial
Applied Biology, Inc. · Canities, Grey Hair
- CT001Phase 31 trial
Cessatech A/S · Pain
- CTO0308Phase 31 trial
Taejoon Pharmaceutical Co., Ltd. · Myopia
- CTP-543Phase 31 trial
Sun Pharmaceutical Industries, Inc. · Alopecia Areata
- D07001-SoftgelPhase 31 trial
InnoPharmax Inc. · Biliary Tract Cancer (BTC)
- DA-001Phase 31 trial
Applied Biology, Inc. · Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia
- DA-007Phase 31 trial
Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects
- DA-5219Phase 31 trial
Dong-A ST Co., Ltd. · Gastritis Acute, Gastritis Chronic
- DA5221-B1Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DA5221-B2Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DA5221-T1Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- DA5221-T2Phase 31 trial
Dong-A ST Co., Ltd. · Type 2 Diabetes
- dabocemagene autoficelFCX-007, see below for FCX-007 descriptionPhase 31 trial
Castle Creek Biosciences, LLC. · Recessive Dystrophic Epidermolysis Bullosa
- DalpciclibPhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Breast Cancer
- DalpiciclibPhase 31 trial
Risen (Suzhou) Pharma Tech Co., Ltd. · Breast Cancer
- DAS181Phase 31 trial
Ansun Biopharma, Inc. · Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised
- Debio 4126Phase 31 trial
Debiopharm International SA · Acromegaly
- Debio 4326Phase 31 trial
Debiopharm International SA · Central Precocious Puberty
- Decartes-08Phase 31 trial
Cartesian Therapeutics · Myasthaenia Gravis
- DEH113Phase 31 trial
EMS · Primary Dysmenorrhea
- DenifanstatPhase 31 trial
Sagimet Biosciences Inc. · Acne Vulgaris
- DeutenzalutamidePhase 31 trial
AstraZeneca · Metastatic Castration-resistant Prostate Cancer
- DIT112Phase 31 trial
EMS · Moderate Pain, Severe Pain
- DLBS1442DismenoPhase 31 trial
Dexa Medica Group · Primary Dysmenorrhea
- DLBS2411RedacidPhase 31 trial
Dexa Medica Group · Functional Dyspepsia
- DLBS3233InlacinPhase 31 trial
Dexa Medica Group · Prediabetes
- DMT310Phase 31 trial
Dermata Therapeutics · Acne Vulgaris
- DMX-200RepagermaniumPhase 31 trial
Dimerix Bioscience Pty Ltd · FSGS
- DTT106Phase 31 trial
EMS · Prostatic Hyperplasia, Benign, Erectile Dysfunction
- DuanorubicinPhase 31 trial
Arog Pharmaceuticals, Inc. · Newly Diagnosed FLT3 Mutated AML
- DW4421Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Erosive Reflux Disease, GERD (Gastroesophageal Reflux Disease)
- DW5121Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- DW51211Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- DW51212Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.